5 Stocks Jim Cramer and Hedge Funds Have In Common

3. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Hedge Fund Holders: 69

Barclays analysts hold an Equal Weight rating on Bristol-Myers Squibb Company (NYSE:BMY) shares as of May 1, alongside a $65 price target.

Bristol-Myers Squibb Company (NYSE:BMY) was spotted in the portfolios of 69 hedge funds in the first quarter. Their total stake value was $1.6 billion.

Cramer notes that while “people have given up on the drug stocks,” he will not give up on Bristol-Myers Squibb Company (NYSE:BMY) “because things are never so rosy that you can’t have a drug stock in your portfolio, and Bristol is a good one.”

Follow Bristol Myers Squibb Co (NYSE:BMY)